Kolltan Pharmaceuticals Revenue

Biotechnology Research • New Haven, Connecticut, United States • 1-10 Employees

Kolltan Pharmaceuticals revenue & valuation

Annual revenue	$10,000,000
Revenue per employee	$1,112,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$32,000,000
Total funding	$60,000,000

Key Contacts at Kolltan Pharmaceuticals

Michael Schmertzler

Ceo

Arthur Altschul

Co-Founder & Chairman

Company overview

Headquarters	300 George Street, Suite 530, New Haven, CT 06511, US
Phone number	+18669083442
Website	kolltan.com
NAICS	541714
Employees	1-10
Socials

About Kolltan Pharmaceuticals

Kolltan, a privately held clinical-stage company, is focused on advancing a new generation of therapeutics in oncology and other diseases by discovering and developing novel biologic agents designed to modulate the function of receptor tyrosine kinases (RTKs). Kolltan is led by an experienced team of executives and scientists with a deep understanding of RTKs, their ligands, and cellular signaling. Located adjacent to the Yale Medical School in New Haven, Connecticut, Kolltan is working in close collaboration with the laboratory of Kolltan co-founder, Dr. Joseph Schlessinger, as well as the Yale medical and scientific community to bring important medicines to cancer patients and other patients with serious diseases. The Company's R&D pipeline is advancing rapidly, with the first clinical trial initiated in January 2014.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Entry

Manager

Employees by Department

Kolltan Pharmaceuticals has 7 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Kolltan Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2014-04-19	7	$60,000,000

Funding Insights

$60,000,000

Total funding amount

$60,000,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Kolltan Pharmaceuticals is located in New Haven, Connecticut, US.

You can reach Kolltan Pharmaceuticals at +18669083442.

Kolltan Pharmaceuticals generates an estimated annual revenue of $10,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Kolltan Pharmaceuticals has an estimated valuation of $32,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Kolltan Pharmaceuticals has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Kolltan Pharmaceuticals has raised a total of $60,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Kolltan Pharmaceuticals

Michael Schmertzler

Ceo

Arthur Altschul

Co-Founder & Chairman

4.8

40,000 users